Journal of Orthopaedic and Sports Physical Therapy Revenue and Competitors
Estimated Revenue & Valuation
- Journal of Orthopaedic and Sports Physical Therapy's estimated annual revenue is currently $18.7M per year.
- Journal of Orthopaedic and Sports Physical Therapy's estimated revenue per employee is $243,000
Employee Data
- Journal of Orthopaedic and Sports Physical Therapy has 77 Employees.
- Journal of Orthopaedic and Sports Physical Therapy grew their employee count by 43% last year.
Journal of Orthopaedic and Sports Physical Therapy's People
Name | Title | Email/Phone |
---|
Journal of Orthopaedic and Sports Physical Therapy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.6M | 27 | 0% | N/A | N/A |
#2 | $443.6M | 1304 | 10% | N/A | N/A |
#3 | $8.9M | 46 | 15% | N/A | N/A |
#4 | $9.1M | 47 | 4% | N/A | N/A |
#5 | $50.8M | 190 | 15% | N/A | N/A |
#6 | $6.6M | 34 | -3% | N/A | N/A |
#7 | $39M | 146 | 5% | N/A | N/A |
#8 | $1876.2M | 5515 | 7% | N/A | N/A |
#9 | $28.9M | 119 | 8% | N/A | N/A |
#10 | $6.8M | 35 | 3% | N/A | N/A |
What Is Journal of Orthopaedic and Sports Physical Therapy?
The Journal of Orthopaedic & Sports Physical Therapy® (JOSPT®) publishes scientifically rigorous, clinically relevant content for physical therapists and others in the health care community to advance musculoskeletal and sports-related practice globally. To this end, JOSPT features the latest evidence-based research and clinical cases in musculoskeletal health, injury, and rehabilitation, including physical therapy, orthopaedics, sports medicine, and biomechanics.
keywords:N/AN/A
Total Funding
77
Number of Employees
$18.7M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.2M | 77 | 54% | N/A |
#2 | $25.4M | 77 | 7% | N/A |
#3 | N/A | 78 | 1% | N/A |
#4 | $24M | 78 | 1% | N/A |
#5 | $3.5M | 78 | 39% | N/A |